Year: 2026

PRESS RELEASE Arcueil, June 12, 2026 2026 half-year financial report release Aramis Group today announces that the company has filed its 2026 half-year financial report, ended March 31, 2026, with the French Financial Markets Authority (Autorité des marchés financiers). Aramis Group 2026 half-year financial report is available on the Company’s website www.aramis.group under “Investors / Regulated information”. *** About Aramis Group – www.aramis.group Aramis Group is the European leader for B2C online used car sales and operates in six countries. A fast-growing group, an e-commerce expert and a vehicle refurbishing pioneer, Aramis Group takes action each day for more sustainable mobility with an offering that is part of the circular economy. Founded in 2001, it has been revolutionizing its market for 25 years, focused on ensuring the satisfaction...

MELBOURNE, Australia, June 12, 2026 (GLOBE NEWSWIRE) — Gelteq Limited (“Gelteq” or the “Company”) today announced the successful completion of its veterinary palatability trials conducted in collaboration with Kemin Industries (“Kemin”), a leading U.S.-based global ingredient manufacturer. The trials were designed to optimise flavour profiles and assess canine acceptance of products powered by Gelteq® technology, the Company’s proprietary gel-based delivery platform. Gelteq tested a variety of products, including a range deliberately formulated with natural bitter compounds that canines would ordinarily reject. The results demonstrated strong canine acceptance across the flavour profiles and confirmed the ability of Gelteq® technology to effectively mask bitter flavour profiles while improving palatability, providing an important...

More than 100 patients treated with ronde-cel in 2L and 3L+ LBCL, with a manufacturing success rate of 97% No Grade ≥ 3 CRS and low rates of Grade ≥ 3 ICANS, supporting outpatient administration Translational data support biological basis for durable responses, including enhanced memory potential of cytotoxic effector cells from CD62L+ enrichment, and CD19/CD20 dual-targeting to overcome low antigen expression PiNACLE pivotal clinical trial in 3L+ setting data update expected in second half of 2026; pivotal data readout expected in mid-2027, with BLA submission to follow in the second half of 2027SOUTH SAN FRANCISCO, Calif., June 12, 2026 (GLOBE NEWSWIRE) — Lyell Immunopharma, Inc. (Nasdaq: LYEL), a late-stage clinical company advancing a pipeline of next-generation chimeric antigen receptor (CAR) T-cell therapies for patients...

New corporate identity reflects the Company’s strategic transition into the global sports and media industry following its business combination with Flash Sports & Media LAFAYETTE, Colo., June 12, 2026 (GLOBE NEWSWIRE) — urban-gro, Inc. (Nasdaq: UGRO) (the “Company”) today announced that, at a special meeting of shareholders held earlier today, shareholders approved the Company’s name change to Flash Sports & Media, Inc. The Company also announced that its common stock is expected to begin trading under the new ticker symbol “FLZH” on The Nasdaq Stock Market, subject to Nasdaq’s processing and effectiveness. The new corporate name reflects the next chapter for the Company as a global sports and media platform focused on the creation, production, commercialization, and monetization of live sports properties, media rights,...

RELEASE Paris, June 12, 2026 INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES COMPRISING THE SHARE CAPITALIn accordance with the provisions of Article L. 233-8 of the French Commercial Code (Code de commerce) and Article 223-16 of the General Regulations of French Autorité des Marchés Financiers (AMF), Hermès international publishes each month, before the 15th day of the following month, the total number of voting rights and the number of shares comprising the share capital if they have varied from those previously published.Date Total number of shares Total number of theoretical voting rights (including treasury stock) Total number of effective voting rights (exercisable at shareholders’ meetings) Publications31 May 2026 105 569 412 179 295 721 178 466 120 12 June 202630 April 2026 105 569 412 179 250...

Share buy-back programme Paris, June 12th, 2026 – JCDecaux SE (Euronext Paris: DEC), the number one outdoor advertising company worldwide, announces the launch of a share buy-back programme. As part of the authorisation granted by the Annual General Meeting on May 13, 2026, JCDecaux has appointed an investment-services provider to purchase an aggregate number of JCDecaux SE shares of up to 331,498, representing c.0.15% of the share capital of the company, over a period extending from June 12, 2026 to September 30, 2026. The shares purchased under this agreement will be used to cover performance share allocations of current or future performance plans. Key Figures for JCDecaux2025 revenue: €3,967.1m N°1 Out-of-Home Media company worldwide A daily audience of 850 million people in 79 countries 1,105,906 advertising panels worldwide Present...

REGULATED INFORMATION                Paris, 12 June 2026 5:45 PM YOUR OPERATIONAL LEASING SOLUTION FOR SUSTAINABLE TRANSPORTATION Disclosure of Share Capital and Voting Rights Disclosure of Share Capital and Voting Rights pursuant to Article L.233-8 II of the French Commercial Code and Article 223-16 of the General Regulations of the Autorité des Marchés Financiers. Register name of the issuer: TOUAX SCA (Euronext Growth Paris: ALTOU)Date Total shares outstanding Total voting rights Total exercisable voting rights*May 31, 2026 6,982,470 8,229,802 8,222,124* excluding rights attached to shares held in treasury **************** TOUAX Group leases out tangible assets (freight railcars, river barges and containers) on a daily basis throughout the world, for its own account and on behalf of third party investors. With €1.3 billion...

More information is available on Aedifica’s website via the link below and can be accessed subject to the usual restrictions.Press release EN Communiqué de presse FR Persbericht NL

  12 June 2026   Announcement no. 8   Pharma Equity Group prevails in international arbitration proceedings and is awarded EUR 10.5 million excluding interest and costs   Pharma Equity Group A/S (“PEG” or the “Company”) today announces that it has received a final and binding international arbitral award rendered by the Danish Institute of Arbitration in the proceedings against Interpatium – Promoção Imobiliária LDA, Madeira, Portugal. The Arbitral Tribunal has ruled entirely in favour of PEG and awarded the Company EUR 10.5 million excluding interest and costs. Interpatium has also been ordered to bear the costs of the arbitration proceedings.   In its final and binding award, the Arbitral Tribunal concluded that PEG is entitled to payment of EUR 10.5 million from Interpatium – Promoção Imobiliária LDA as a result...

New York CitySysco truck drives past Statue of LibertyDallasSysco truck driving through DallasSeattleSysco truck driving through SeattleHOUSTON, June 12, 2026 (GLOBE NEWSWIRE) — Sysco Corporation has spent months planning, hiring, stocking inventory and expanding its US fleet in 11 host cities to make sure the nearly 5 million visitors are properly fed while watching the 2026 FIFA World Cup games. A task force of dozens of Sysco colleagues collaborated with local officials and stakeholders to understand and respond to expected demand, navigate complex logistics and security arrangements and make sure each city and all restaurant customers score big with visitors. To help customers succeed during an event that is expected to have billions of dollars of economic impact in host cities, Sysco has:Prepared...